EP-1252 Brain metastases postoperative stereotactic RT

WBRT free survival predicted by an external nomogram

A. Mousli, B. Bihin, T. Gustin, G. Koerts, M. Mouchamps, J. Daisne

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)S688-S689
JournalRadiotherapy and Oncology
Volume133
Issue numberSupplément 1
DOIs
Publication statusPublished - Apr 2019

Cite this

Mousli, A. ; Bihin, B. ; Gustin, T. ; Koerts, G. ; Mouchamps, M. ; Daisne, J. / EP-1252 Brain metastases postoperative stereotactic RT : WBRT free survival predicted by an external nomogram. In: Radiotherapy and Oncology. 2019 ; Vol. 133, No. Supplément 1. pp. S688-S689.
@article{9a6b452289c446d3ac835fcf88144606,
title = "EP-1252 Brain metastases postoperative stereotactic RT: WBRT free survival predicted by an external nomogram",
author = "A. Mousli and B. Bihin and T. Gustin and G. Koerts and M. Mouchamps and J. Daisne",
year = "2019",
month = "4",
doi = "10.1016/s0167-8140(19)31672-x",
language = "English",
volume = "133",
pages = "S688--S689",
journal = "Radiotherapy and Oncology",
issn = "0167-8140",
publisher = "Elsevier",
number = "Suppl{\'e}ment 1",

}

EP-1252 Brain metastases postoperative stereotactic RT : WBRT free survival predicted by an external nomogram. / Mousli, A.; Bihin, B.; Gustin, T.; Koerts, G.; Mouchamps, M.; Daisne, J.

In: Radiotherapy and Oncology, Vol. 133, No. Supplément 1, 04.2019, p. S688-S689.

Research output: Contribution to journalArticle

TY - JOUR

T1 - EP-1252 Brain metastases postoperative stereotactic RT

T2 - WBRT free survival predicted by an external nomogram

AU - Mousli, A.

AU - Bihin, B.

AU - Gustin, T.

AU - Koerts, G.

AU - Mouchamps, M.

AU - Daisne, J.

PY - 2019/4

Y1 - 2019/4

UR - http://www.mendeley.com/research/ep1252-brain-metastases-postoperative-stereotactic-rt-wbrt-free-survival-predicted-external-nomogram

U2 - 10.1016/s0167-8140(19)31672-x

DO - 10.1016/s0167-8140(19)31672-x

M3 - Article

VL - 133

SP - S688-S689

JO - Radiotherapy and Oncology

JF - Radiotherapy and Oncology

SN - 0167-8140

IS - Supplément 1

ER -